Singapore's ABC Impact to invest in AC Health
ABC Impact will acquire an approximately 16% minority stake in AC Health, with the primary capital investment being used to support the company's aim of creating an integrated healthcare ecosystem to benefit the people of the country.
This investment will strengthen AC Health's growth across its core pillars, including hospitals, retail pharmacies and multi-speciality clinics.
AC Health plans to expand its network to at least ten hospitals, 300 clinics, and 1,150 pharmacies by 2027.
This expansion will be achieved through targeted acquisitions and organic growth, assisted by the new capital from ABC Impact.
With its focus on Asia, ABC Impact brings regional insights and networks to the partnership.
The investor has made healthcare investments in China, India, and Vietnam and sees potential for collaboration and knowledge-sharing that could enhance its care model in the Philippines.
AC Health president and CEO Paolo Borromeo said: 'ABC Impact's investment reinforces the strength of our integrated model and our commitment to making healthcare more inclusive.
'This partnership creates valuable opportunities for knowledge exchange, technology transfer, and the adoption of global best practices, further enabling AC Health to raise the bar in care quality, patient safety, and operational efficiency as it moves toward world-class standards.'
This move combines the integrated delivery network of AC Health with ABC Impact's experience in investing in inclusive healthcare solutions.
ABC Impact also looks to build on its regional track record of purpose-driven capital infusions, which encompasses companies such as DCDC Kidney Care in India, Kim Dental in Vietnam, and clinical research organisation HiRo, which operates across the Asia Pacific and the US.
In addition, the move strengthens the partnership between the Ayala Group, which AC Health is a part of, and the Temasek ecosystem, which supports ABC Impact.
For this transaction, BofA Securities served as the exclusive financial adviser to AC Health. The completion of ABC Impact's investment is contingent upon the fulfilment of closing conditions.
"Singapore's ABC Impact to invest in AC Health" was originally created and published by Hospital Management, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
Insurer Suncorp's full-year profit up 8%, announces $262 million share buyback
(Reuters) -Australian insurer Suncorp reported a better-than-expected full-year cash earnings on Thursday, driven by improved underlying insurance margins and higher investment returns, and announced a share buyback plan of up to A$400 million ($261.72 million). The general insurer's underlying insurance trading ratio, a key profitability indicator, ticked 8 basis points higher to 11.9% in the year to June 30, while net investment returns jumped 16% to A$766 million. Natural hazard costs came in at A$1.36 billion, more than A$200 million below its allowance for the year. As a result, the general insurer's cash earnings jumped to A$1.49 billion for the year ended June 30, ahead of the Visible Alpha consensus estimate of A$1.47 billion and last year's A$1.37 billion. The Brisbane-headquartered firm declared a final dividend of 49 Australian cents per share, up from 44 Australian cents per share last year. ($1 = 1.5284 Australian dollars) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
35 minutes ago
- Yahoo
Is Wall Street Bullish or Bearish on Welltower Stock?
Welltower Inc. (WELL) is a leading healthcare REIT with a $112.4 billion market cap. Headquartered in Toledo, Ohio, the company specializes in senior housing, post-acute care, and outpatient medical properties across North America and the U.K. Shares of WELL have delivered a robust performance over the past year, with its shares soaring 43.1%, sharply outpacing the S&P 500 Index's ($SPX) 19.3% rally. In 2025 alone, the stock has advanced 33.3%, outpacing the $SPX, which has returned 8.4% on a YTD basis. More News from Barchart This High-Yield (7%) Dividend Stock Is Down Significantly in 2025. Should You Buy the Dip? Dear CoreWeave Stock Fans, Mark Your Calendars for August 14 Tesla Is Axing Its Dojo Supercomputer Plans. What Does That Mean for TSLA Stock Here? Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! Zooming in further, WELL stock has outperformed the Real Estate Select Sector SPDR Fund's (XLRE) 1.9% decline over the past 52 weeks and marginal rise on a YTD basis. On Jul. 28, Welltower released its fiscal 2025 second-quarter earnings and its shares climbed 4.9% in the next trading session. The company achieved revenue of $2.55 billion, exceeding the consensus estimate of $2.47 billion, and posted earnings per share of $0.45, meeting forecasts. Normalized Funds from Operations per share increased by 21.9% year-over-year to $1.28, driven by a 13.8% rise in same-store net operating income. For the current fiscal year, ending in December, analysts expect Welltower's EPS to grow 18.1% to $5.10. The company's earnings surprise history is impressive. It beat the consensus estimate in each of the last four quarters. Among the 18 analysts covering WELL stock, the consensus rating is a 'Strong Buy.' That's based on 13 'Strong Buy' ratings, two 'Moderate Buys,' and three 'Holds.' This configuration is slightly less bullish than two months ago, with 14 'Strong Buy' ratings. On July 30, Evercore ISI analyst Steve Sakwa maintained an "In-Line" rating on Welltower and raised the price target by 8.02%, from $162 to $175. The mean price target of $175.47 represents a 4.4% premium to the current market prices. Its Street-high price target of $240 implies the stock could rally as much as 44.2%. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
36 minutes ago
- Yahoo
Man took diet advice from ChatGPT, ended up hospitalized with hallucinations
A man was hospitalized for weeks and suffered from hallucinations after poisoning himself based on dietary advice from ChatGPT. A case study published on Aug. 5 in the Annals of Internal Medicine, an academic journal, states the 60-year-old man decided he wanted to eliminate salt from his diet completely. To do so, he asked ChatGPT for an alternative to salt, or sodium chloride, to which the AI chatbot suggested sodium bromide, a compound historically used in pharmaceuticals and manufacturing. While the journal noted that doctors were unable to review the original AI chat logs and that the bot likely suggested the substitution for another purpose, such as cleaning, the man purchased sodium bromide and used it in place of table salt for three months. As a result, he ended up in the ER with paranoid delusions, despite having no history of mental health problems. Convinced that his neighbor was poisoning him, the man was reluctant to even accept water from the hospital, despite reporting extreme thirst. He continued to experience increased paranoia, as well as auditory and visual hallucinations, eventually landing him an involuntary psychiatric hold after he tried to escape during treatment. What was happening to the man? Doctors determined that the man was suffering from bromide toxicity (or bromism), which can result in neurological and psychiatric symptoms, as well as others experienced by the man, including acne and cherry angiomas (bumps on the skin), fatigue, insomnia, subtle ataxia (clumsiness) and polydipsia (excessive thirst). Other symptoms of bromism can include nausea and vomiting, diarrhea, tremors or seizures, drowsiness, headache, weakness, weight loss, kidney damage, respiratory failure and coma, according to iCliniq. Bromism was once far more common due to bromide salts having been used in everyday products. In the early 20th Century, it was used in over-the-counter medications, often resulting in neuropsychiatric and dermatological symptoms, according to the study's authors. Incidents of such poisoning saw a sharp decline when the Food and Drug Administration phased out the use of bromides in pharmaceuticals between the mid 70s and late 1980s. The man was treated at the hospital for three weeks, over which time his symptoms progressively improved. USA TODAY reached out to OpenAI, the maker of ChatGPT, for comment on Wednesday, Aug. 13, but has not received a response. The company provided Fox News Digital with a statement, saying, "Our terms say that ChatGPT is not intended for use in the treatment of any health condition, and is not a substitute for professional advice. We have safety teams working on reducing risks and have trained our AI systems to encourage people to seek professional guidance." AI can 'fuel the spread of misinformation,' doctors say Doctors involved in the case study said they suspected that the patient had used ChatGPT version 3.5 or 4.0, the former of which they tested in an attempt to replicate the answers the man received. While the study's authors noted that they couldn't know exactly what the man was told without the original chat log, they did receive a suggestion for bromide as a replacement for chloride in their tests. "Though the reply stated that context matters, it did not provide a specific health warning, nor did it inquire about why we wanted to know, as we presume a medical professional would do," said study authors Dr. Audrey Eichenberger, Dr. Stephen Thielke and Dr. Adam Van Buskirk. AI carries the risk of providing information like this without context, according to the doctors. For example, it is unlikely that a medical expert would have mentioned sodium bromide at all if a patient asked for a salt substitute. "Thus, it is important to consider that ChatGPT and other AI systems can generate scientific inaccuracies, lack the ability to critically discuss results, and ultimately fuel the spread of misinformation," according to the study. This article originally appeared on USA TODAY: Man hospitalized after taking ChatGPT diet advice, study says Solve the daily Crossword
